{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:51:41Z","timestamp":1775091101508,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81901108"],"award-info":[{"award-number":["No. 81901108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10072-023-06729-5","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T12:06:10Z","timestamp":1678709170000},"page":"2743-2751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Soluble TREM2 in body fluid in Alzheimer\u2019s disease and Parkinson\u2019s disease"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6392-1128","authenticated-orcid":false,"given":"Lihua","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"6729_CR1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.5713\/ajas.15.0413","volume":"29","author":"HY Wang","year":"2016","unstructured":"Wang HY, Lin ZL, Yu XF, Bao Y, Cui XS, Kim NH (2016) Computational prediction of Alzheimer\u2019s and Parkinson\u2019s disease microRNAs in domestic animals. Asian-Australas J Anim Sci 29:782\u2013792","journal-title":"Asian-Australas J Anim Sci"},{"key":"6729_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356","journal-title":"Science"},{"key":"6729_CR3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","volume":"16","author":"JA Obeso","year":"2010","unstructured":"Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH, Halliday G (2010) Missing pieces in the Parkinson\u2019s disease puzzle. Nat Med 16:653\u2013661","journal-title":"Nat Med"},{"key":"6729_CR4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304\u2013377","journal-title":"Intensive Care Med"},{"key":"6729_CR5","doi-asserted-by":"crossref","first-page":"726.e711","DOI":"10.1016\/j.neurobiolaging.2013.09.009","volume":"35","author":"E Cuyvers","year":"2014","unstructured":"Cuyvers E, Bettens K, Philtjens S, Van Langenhove T, Gijselinck I, van der Zee J, Engelborghs S, Vandenbulcke M, Van Dongen J, Geerts N, Maes G, Mattheijssens M, Peeters K, Cras P, Vandenberghe R, De Deyn PP, Van Broeckhoven C, Cruts M, Sleegers K (2014) Investigating the role of rare heterozygous TREM2 variants in Alzheimer\u2019s disease and frontotemporal dementia. Neurobiol Aging 35:726.e711-729","journal-title":"Neurobiol Aging"},{"key":"6729_CR6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","volume":"70","author":"RJ Guerreiro","year":"2013","unstructured":"Guerreiro RJ, Lohmann E, Br\u00e1s JM, Gibbs JR, Rohrer JD, Gurunlian N, Dursun B, Bilgic B, Hanagasi H, Gurvit H, Emre M, Singleton A, Hardy J (2013) Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol 70:78\u201384","journal-title":"JAMA Neurol"},{"key":"6729_CR7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1468-1331.2010.03311.x","volume":"18","author":"Y Numasawa","year":"2011","unstructured":"Numasawa Y, Yamaura C, Ishihara S, Shintani S, Yamazaki M, Tabunoki H, Satoh JI (2011) Nasu-Hakola disease with a splicing mutation of TREM2 in a Japanese family. Eur J Neurol 18:1179\u20131183","journal-title":"Eur J Neurol"},{"key":"6729_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","volume":"11","author":"A Heslegrave","year":"2016","unstructured":"Heslegrave A, Heywood W, Paterson R, Magdalinou N, Svensson J, Johansson P, \u00d6hrfelt A, Blennow K, Hardy J, Schott J, Mills K, Zetterberg H (2016) Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer\u2019s disease. Mol Neurodegener 11:3","journal-title":"Mol Neurodegener"},{"key":"6729_CR9","doi-asserted-by":"crossref","unstructured":"Ewers M, Franzmeier N, Suarez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, Piccio L, Cruchaga C, Deming Y, Dichgans M, Trojanowski JQ, Shaw LM, Weiner MW, Haass C, Alzheimers Dis Neuroimaging I (2019) Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease. Sci Transl Med 11:507","DOI":"10.1126\/scitranslmed.aav6221"},{"key":"6729_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13195-016-0182-1","volume":"8","author":"K Henjum","year":"2016","unstructured":"Henjum K, Almdahl IS, \u00c5rskog V, Minthon L, Hansson O, Fladby T, Nilsson LN (2016) Cerebrospinal fluid soluble TREM2 in aging and Alzheimer\u2019s disease. Alzheimers Res Ther 8:17","journal-title":"Alzheimers Res Ther"},{"key":"6729_CR11","doi-asserted-by":"crossref","unstructured":"Peng G, Qiu J, Liu H, Zhou M, Huang S, Guo W, Lin Y, Chen X, Li Z, Li G, Zhang W, Zhang Y, Li X, Wu Z, Wei L, Yang X, Zhu X, Mo M, Xu P (2020) Analysis of cerebrospinal fluid soluble TREM2 and polymorphisms in sporadic Parkinson\u2019s disease in a Chinese population 70(2):294\u2013301","DOI":"10.1007\/s12031-019-01424-7"},{"key":"6729_CR12","doi-asserted-by":"crossref","first-page":"892493","DOI":"10.3389\/fnagi.2022.892493","volume":"14","author":"Q Qin","year":"2022","unstructured":"Qin Q, Wan H, Wang D, Li J, Qu Y, Zhao J, Li J, Xue Z (2022) The association of CSF sTREM2 with cognitive decline and its dynamic change in Parkinson\u2019s disease: analysis of the PPMI cohort. Front Aging Neurosci 14:892493","journal-title":"Front Aging Neurosci"},{"key":"6729_CR13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3233\/JAD-130854","volume":"38","author":"N Hu","year":"2014","unstructured":"Hu N, Tan MS, Yu JT, Sun L, Tan L, Wang YL, Jiang T, Tan L (2014) Increased expression of TREM2 in peripheral blood of Alzheimer\u2019s disease patients. J Alzheimers Dis 38:497\u2013501","journal-title":"J Alzheimers Dis"},{"key":"6729_CR14","doi-asserted-by":"crossref","first-page":"243ra286","DOI":"10.1126\/scitranslmed.3009093","volume":"6","author":"G Kleinberger","year":"2014","unstructured":"Kleinberger G, Yamanishi Y, Su\u00e1rez-Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger-Weinzierl A, Mazaheri F, Tahirovic S, Lle\u00f3 A, Alcolea D, Fortea J, Willem M, Lammich S, Molinuevo JL, S\u00e1nchez-Valle R, Antonell A, Ramirez A, Heneka MT, Sleegers K, van der Zee J, Martin JJ, Engelborghs S, Demirtas-Tatlidede A, Zetterberg H, Van Broeckhoven C, Gurvit H, Wyss-Coray T, Hardy J, Colonna M, Haass C (2014) TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med 6:243ra286","journal-title":"Sci Transl Med"},{"key":"6729_CR15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jalz.2016.06.005","volume":"12","author":"JD Gispert","year":"2016","unstructured":"Gispert JD, Su\u00e1rez-Calvet M, Mont\u00e9 GC, Tucholka A, Falcon C, Rojas S, Rami L, S\u00e1nchez-Valle R, Llad\u00f3 A, Kleinberger G, Haass C, Molinuevo JL (2016) Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer\u2019s disease. Alzheimers Dement 12:1259\u20131272","journal-title":"Alzheimers Dement"},{"key":"6729_CR16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","volume":"131","author":"L Piccio","year":"2016","unstructured":"Piccio L, Deming Y, Del-\u00c1guila JL, Ghezzi L, Holtzman DM, Fagan AM, Fenoglio C, Galimberti D, Borroni B, Cruchaga C (2016) Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status. Acta Neuropathol 131:925\u2013933","journal-title":"Acta Neuropathol"},{"key":"6729_CR17","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","volume":"8","author":"M Su\u00e1rez-Calvet","year":"2016","unstructured":"Su\u00e1rez-Calvet M, Kleinberger G, Araque Caballero M, Brendel M, Rominger A, Alcolea D, Fortea J, Lle\u00f3 A, Blesa R, Gispert JD, S\u00e1nchez-Valle R, Antonell A, Rami L, Molinuevo JL, Brosseron F, Trasch\u00fctz A, Heneka MT, Struyfs H, Engelborghs S, Sleegers K, Van Broeckhoven C, Zetterberg H, Nellg\u00e5rd B, Blennow K, Crispin A, Ewers M, Haass C (2016) sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers. EMBO Mol Med 8:466\u2013476","journal-title":"EMBO Mol Med"},{"key":"6729_CR18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.dadm.2016.12.002","volume":"6","author":"JD Gispert","year":"2017","unstructured":"Gispert JD, Mont\u00e9 GC, Su\u00e1rez-Calvet M, Falcon C, Tucholka A, Rojas S, Rami L, S\u00e1nchez-Valle R, Llad\u00f3 A, Kleinberger G, Haass C, Molinuevo JL (2017) The APOE \u03b54 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer\u2019s disease but not those of sTREM2. Alzheimers Dement (Amst) 6:50\u201359","journal-title":"Alzheimers Dement (Amst)"},{"key":"6729_CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2018.03.003","volume":"319","author":"LM Bekris","year":"2018","unstructured":"Bekris LM, Khrestian M, Dyne E, Shao Y, Pillai JA, Rao SM, Bemiller SM, Lamb B, Fernandez HH, Leverenz JB (2018) Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease. J Neuroimmunol 319:19\u201327","journal-title":"J Neuroimmunol"},{"key":"6729_CR20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-018-0353-3","volume":"10","author":"F Brosseron","year":"2018","unstructured":"Brosseron F, Trasch\u00fctz A, Widmann CN, Kummer MP, Tacik P, Santarelli F, Jessen F, Heneka MT (2018) Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer\u2019s disease. Alzheimers Res Ther 10:25","journal-title":"Alzheimers Res Ther"},{"key":"6729_CR21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fnagi.2019.00297","volume":"11","author":"C Liu","year":"2019","unstructured":"Liu C, Yu J (2019) Genome-wide association studies for cerebrospinal fluid soluble TREM2 in Alzheimer\u2019s disease. Front Aging Neurosci 11:297","journal-title":"Front Aging Neurosci"},{"key":"6729_CR22","doi-asserted-by":"crossref","unstructured":"Morenas-Rodriguez E, Alcolea D, Suarez-Calvet M, Munoz-Llahuna L, Vilaplana E, Sala I, Subirana A, Querol-Vilaseca M, Carmona-Iragui M, Illan-Gala I, Ribosa-Nogue R, Blesa R, Haass C, Fortea J, Lleo A (2019) Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer\u2019s disease. Sci Rep 9(1):7803","DOI":"10.1038\/s41598-019-44173-8"},{"key":"6729_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","volume":"14","author":"M Su\u00e1rez-Calvet","year":"2019","unstructured":"Su\u00e1rez-Calvet M, Morenas-Rodr\u00edguez E, Kleinberger G, Schlepckow K, Araque Caballero M, Franzmeier N, Capell A, Fellerer K, Nuscher B, Eren E, Levin J, Deming Y, Piccio L, Karch CM, Cruchaga C, Shaw LM, Trojanowski JQ, Weiner M, Ewers M, Haass C (2019) Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology. Mol Neurodegener 14:1","journal-title":"Mol Neurodegener"},{"key":"6729_CR24","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3233\/JAD-191254","volume":"74","author":"G Banerjee","year":"2020","unstructured":"Banerjee G, Ambler G, Keshavan A, Paterson RW, Foiani MS, Toombs J, Heslegrave A, Dickson JC, Fraioli F, Groves AM, Lunn MP, Fox NC, Zetterberg H, Schott JM, Werring DJ (2020) Cerebrospinal fluid biomarkers in cerebral amyloid angiopathy. J Alzheimers Dis 74:1189\u20131201","journal-title":"J Alzheimers Dis"},{"key":"6729_CR25","first-page":"e12128","volume":"12","author":"TH Edwin","year":"2020","unstructured":"Edwin TH, Henjum K, Nilsson LNG, Watne LO, Persson K, Eldholm RS, Saltvedt I, Halaas NB, Selb\u00e6k G, Engedal K, Strand BH, Knapskog AB (2020) A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer\u2019s disease. Alzheimers Dement (Amst) 12:e12128","journal-title":"Alzheimers Dement (Amst)"},{"key":"6729_CR26","doi-asserted-by":"crossref","first-page":"627931","DOI":"10.3389\/fmolb.2020.627931","volume":"7","author":"E Ferri","year":"2020","unstructured":"Ferri E, Rossi PD, Geraci A, Ciccone S, Cesari M, Arosio B (2020) The sTREM2 concentrations in the blood: a marker of neurodegeneration? Front Mol Biosci 7:627931","journal-title":"Front Mol Biosci"},{"key":"6729_CR27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-020-00407-2","volume":"15","author":"N Franzmeier","year":"2020","unstructured":"Franzmeier N, Su\u00e1rez-Calvet M, Frontzkowski L, Moore A, Hohman TJ, Morenas-Rodriguez E, Nuscher B, Shaw L, Trojanowski JQ, Dichgans M, Kleinberger G, Haass C, Ewers M (2020) Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration. Mol Neurodegener 15:57","journal-title":"Mol Neurodegener"},{"key":"6729_CR28","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/cercor\/bhz240","volume":"30","author":"NB Halaas","year":"2020","unstructured":"Halaas NB, Henjum K, Blennow K, Dakhil S, Idland AV, Nilsson LN, Sederevicius D, Vidal-Pi\u00f1eiro D, Walhovd KB, Wyller TB, Zetterberg H, Watne LO, Fjell AM (2020) CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults. Cereb Cortex 30:2295\u20132306","journal-title":"Cereb Cortex"},{"key":"6729_CR29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13024-020-00374-8","volume":"15","author":"LZ Ma","year":"2020","unstructured":"Ma LZ, Tan L, Bi YL, Shen XN, Xu W, Ma YH, Li HQ, Dong Q, Yu JT (2020) Dynamic changes of CSF sTREM2 in preclinical Alzheimer\u2019s disease: the CABLE study. Mol Neurodegener 15:25","journal-title":"Mol Neurodegener"},{"key":"6729_CR30","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/alz.12131","volume":"16","author":"M Mil\u00e0-Alom\u00e0","year":"2020","unstructured":"Mil\u00e0-Alom\u00e0 M, Salvad\u00f3 G, Gispert JD, Vilor-Tejedor N, Grau-Rivera O, Sala-Vila A, S\u00e1nchez-Benavides G, Arenaza-Urquijo EM, Crous-Bou M, Gonz\u00e1lez-de-Ech\u00e1varri JM, Minguillon C, Fauria K, Simon M, Kollmorgen G, Zetterberg H, Blennow K, Su\u00e1rez-Calvet M, Molinuevo JL (2020) Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer\u2019s continuum. Alzheimers Dement 16:1358\u20131371","journal-title":"Alzheimers Dement"},{"key":"6729_CR31","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3233\/JAD-191120","volume":"73","author":"BS Rauchmann","year":"2020","unstructured":"Rauchmann BS, Sadlon A, Perneczky R (2020) Soluble TREM2 and inflammatory proteins in Alzheimer\u2019s disease cerebrospinal fluid. J Alzheimers Dis 73:1615\u20131626","journal-title":"J Alzheimers Dis"},{"key":"6729_CR32","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/brain\/awaa021","volume":"143","author":"EN Wilson","year":"2020","unstructured":"Wilson EN, Swarovski MS, Linortner P, Shahid M, Zuckerman AJ, Wang Q, Channappa D, Minhas PS, Mhatre SD, Plowey ED, Quinn JF, Zabetian CP, Tian L, Longo FM, Cholerton B, Montine TJ, Poston KL, Andreasson KI (2020) Soluble TREM2 is elevated in Parkinson\u2019s disease subgroups with increased CSF tau. Brain 143:932\u2013943","journal-title":"Brain"},{"key":"6729_CR33","doi-asserted-by":"crossref","first-page":"e0257372","DOI":"10.1371\/journal.pone.0257372","volume":"16","author":"M Bartl","year":"2021","unstructured":"Bartl M, Dakna M, Galasko D, Hutten SJ, Foroud T, Quan M, Marek K, Siderowf A, Franz J, Trenkwalder C, Mollenhauer B (2021) Biomarkers of neurodegeneration and glial activation validated in Alzheimer\u2019s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson\u2019s disease. PLoS One 16:e0257372","journal-title":"PLoS One"},{"key":"6729_CR34","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00401-021-02296-1","volume":"141","author":"D Diaz-Lucena","year":"2021","unstructured":"Diaz-Lucena D, Kruse N, Thune K, Schmitz M, Villar-Pique A, da Cunha JEG, Hermann P, Lopez-Perez O, Andres-Benito P, Ladogana A, Calero M, Vidal E, Riggert J, Pineau H, Sim V, Zetterberg H, Blennow K, del Rio JA, Marin-Moreno A, Espinosa JC, Torres JM, Sanchez-Valle R, Mollenhauer B, Ferrer I, Zerr I, Llorens F (2021) TREM2 expression in the brain and biological fluids in prion diseases. Acta Neuropathol 141:841\u2013859","journal-title":"Acta Neuropathol"},{"key":"6729_CR35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13195-021-00943-z","volume":"13","author":"LZ Ma","year":"2021","unstructured":"Ma LZ, Hu H, Wang ZT, Ou YN, Dong Q, Tan L, Yu JT (2021) P-tau and neurodegeneration mediate the effect of \u03b2-amyloid on cognition in non-demented elders. Alzheimers Res Ther 13:200","journal-title":"Alzheimers Res Ther"},{"key":"6729_CR36","doi-asserted-by":"crossref","first-page":"753210","DOI":"10.3389\/fnagi.2021.753210","volume":"13","author":"M Mo","year":"2021","unstructured":"Mo M, Tang Y, Wei L, Qiu J, Peng G, Lin Y, Zhou M, Dai W, Zhang Z, Chen X, Liu H, Ding L, Ye P, Wu Y, Zhu X, Wu Z, Guo W, Xu P (2021) Soluble triggering receptor expressed on myeloid cells 2 from cerebrospinal fluid in sleep disorders related to Parkinson\u2019s disease. Front Aging Neurosci 13:753210","journal-title":"Front Aging Neurosci"},{"key":"6729_CR37","doi-asserted-by":"crossref","unstructured":"Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S (2021) Systematic assessment of 10 biomarker candidates focusing on \u03b1-synuclein-related disorders. Mov Disord 36(12):2874\u20132887","DOI":"10.1002\/mds.28738"},{"key":"6729_CR38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/alz.12204","volume":"17","author":"C Van Hulle","year":"2021","unstructured":"Van Hulle C, Jonaitis EM, Betthauser TJ, Batrla R, Wild N, Kollmorgen G, Andreasson U, Okonkwo O, Bendlin BB, Asthana S, Carlsson CM, Johnson SC, Zetterberg H, Blennow K (2021) An examination of a novel multipanel of CSF biomarkers in the Alzheimer\u2019s disease clinical and pathological continuum. Alzheimers Dement 17:431\u2013445","journal-title":"Alzheimers Dement"},{"key":"6729_CR39","doi-asserted-by":"crossref","first-page":"848180","DOI":"10.3389\/fnagi.2022.848180","volume":"14","author":"YH Chen","year":"2022","unstructured":"Chen YH, Lin RR, Huang HF, Xue YY, Tao QQ (2022) Microglial activation, tau pathology, and neurodegeneration biomarkers predict longitudinal cognitive decline in Alzheimer\u2019s disease continuum. Front Aging Neurosci 14:848180","journal-title":"Front Aging Neurosci"},{"key":"6729_CR40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neurobiolaging.2022.06.013","volume":"118","author":"RL Winfree","year":"2022","unstructured":"Winfree RL, Dumitrescu L, Blennow K, Zetterberg H, Gifford KA, Pechman KR, Jefferson AL, Hohman TJ (2022) Biological correlates of elevated soluble TREM2 in cerebrospinal fluid. Neurobiol Aging 118:88\u201398","journal-title":"Neurobiol Aging"},{"key":"6729_CR41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neulet.2018.08.038","volume":"686","author":"D Liu","year":"2018","unstructured":"Liu D, Cao B, Zhao Y, Huang H, McIntyre RS, Rosenblat JD, Zhou H (2018) Soluble TREM2 changes during the clinical course of Alzheimer\u2019s disease: a meta-analysis. Neurosci Lett 686:10\u201316","journal-title":"Neurosci Lett"},{"key":"6729_CR42","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awn217","volume":"131","author":"L Piccio","year":"2008","unstructured":"Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, Rinker J 2nd, Naismith RT, Panina-Bordignon P, Passini N, Galimberti D, Scarpini E, Colonna M, Cross AH (2008) Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain 131:3081\u20133091","journal-title":"Brain"},{"key":"6729_CR43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13024-017-0197-5","volume":"12","author":"TR Jay","year":"2017","unstructured":"Jay TR, von Saucken VE, Landreth GE (2017) TREM2 in neurodegenerative diseases. Mol Neurodegener 12:56","journal-title":"Mol Neurodegener"},{"key":"6729_CR44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn.2016.7","volume":"17","author":"M Colonna","year":"2016","unstructured":"Colonna M, Wang Y (2016) TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat Rev Neurosci 17:201\u2013207","journal-title":"Nat Rev Neurosci"},{"key":"6729_CR45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","volume":"23","author":"FL Yeh","year":"2017","unstructured":"Yeh FL, Hansen DV, Sheng M (2017) TREM2, microglia, and neurodegenerative diseases. Trends Mol Med 23:512\u2013533","journal-title":"Trends Mol Med"},{"key":"6729_CR46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/alzrt178","volume":"5","author":"TE Golde","year":"2013","unstructured":"Golde TE, Streit WJ, Chakrabarty P (2013) Alzheimer\u2019s disease risk alleles in TREM2 illuminate innate immunity in Alzheimer\u2019s disease. Alzheimers Res Ther 5:24","journal-title":"Alzheimers Res Ther"},{"key":"6729_CR47","doi-asserted-by":"crossref","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","volume":"288","author":"P Wunderlich","year":"2013","unstructured":"Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, Walter J (2013) Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage. J Biol Chem 288:33027\u201333036","journal-title":"J Biol Chem"},{"key":"6729_CR48","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12974-020-01878-2","volume":"17","author":"J Yang","year":"2020","unstructured":"Yang J, Fu Z, Zhang X, Xiong M, Meng L, Zhang Z (2020) TREM2 ectodomain and its soluble form in Alzheimer\u2019s disease. J Neuroinflammation 17:204","journal-title":"J Neuroinflammation"},{"key":"6729_CR49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J (2013) TREM2 variants in Alzheimer\u2019s disease. N Engl J Med 368:117\u2013127","journal-title":"N Engl J Med"},{"key":"6729_CR50","first-page":"1519.e1511","volume":"34","author":"MB Harms","year":"2013","unstructured":"Harms MB, Neumann D, Benitez BA, Cooper B, Carrell D, Racette BA, Perlmutter JS, Goate A, Cruchaga C (2013) Parkinson disease is not associated with C9ORF72 repeat expansions. Neurobiol Aging 34:1519.e1511\u20131512","journal-title":"Neurobiol Aging"},{"key":"6729_CR51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.expneurol.2018.01.016","volume":"302","author":"M Ren","year":"2018","unstructured":"Ren M, Guo Y, Wei X, Yan S, Qin Y, Zhang X, Jiang F, Lou H (2018) TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson\u2019s disease. Exp Neurol 302:205\u2013213","journal-title":"Exp Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06729-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-06729-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06729-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T08:15:36Z","timestamp":1689236136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-06729-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["6729"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-06729-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"6 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree with the content and approve the publication of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}